SCHEMBL23801221

SCHEMBL23801221

C=C(C)[C@@H]1CC[C@@H](C)C[C@H]1c1c(O)cc(CCC)cc1O

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 10/20 0.55
▸ CNR2 P34972 9/20 0.54
▸ CNR1 P21554 5/20 0.54
▸ TRPV1 Q8NER1 3/20 0.54
▸ CYP1A1 P04798 2/20 0.54
▸ CYP2D6 P10635 2/20 0.54
▸ CYP2B6 P20813 2/20 0.54
▸ SLC6A2 P23975 2/20 0.54
▸ CYP2C19 P33261 2/20 0.54
▸ SLC6A3 Q01959 2/20 0.54
▸ TRPM8 Q7Z2W7 2/20 0.54
▸ GPR55 Q9Y2T6 2/20 0.54
▸ TRPA1 O75762 1/20 0.54
▸ GPR6 P46095 1/20 0.54
▸ NAAA Q02083 1/20 0.54
▸ TRPV3 Q8NET8 1/20 0.54
▸ TRPV4 Q9HBA0 1/20 0.54
▸ DAGLA Q9Y4D2 1/20 0.54
▸ TRPV2 Q9Y5S1 1/20 0.54
▸ MLNR O43193 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16917913 1.00 OPRM1 (0.55) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL18271875 1.00 OPRM1 (0.55) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL22564623 1.00 OPRM1 (0.55) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL13214083 0.91 OPRM1 (0.68) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL23868462 0.91 OPRM1 (0.68) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL16084557 0.91 OPRM1 (0.68) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL31545434 0.78 OPRM1 (0.51) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL25560752 0.78 OPRM1 (0.51) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL25560749 0.78 OPRM1 (0.51) OPRM1CNR2CNR1TRPV1CYP1A1
SCHEMBL22910025 0.76 OPRM1 (0.64) OPRM1CNR2CNR1TRPV1CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021178899-A1 USE OF CANNABANOIDS IN THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY PANIGRAHI DIPAK (US) 2021-09-10 — — WO disclosed
Send feedback